Browsing Tag
RASolute 302
1 post
Revolution Medicines wins FDA approval for Rasonque after 60% reduction in death risk
The FDA has approved Revolution Medicines’ Rasonque for previously treated metastatic pancreatic adenocarcinoma after a Phase 3 trial showed median overall survival of 13.2 months versus 6.7 months with chemotherapy.